Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

Annals of Hematology

Volumn 81, Issue 7, 2002, Pages 410-413

  Buckanovich, R J ^a   Liu, G ^a   Stricker, C ^a   Luger, S M ^a   Stadtmauer, E A ^a   Schuster, S J ^a   Duffy, K ^a   Tsai, D ^a   Pruitt, A ^a   Porter, David ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Graft versus lymphoma; Nonmyeloablative allogeneic stem cell transplant; Progressive multifocal leukoencephalopathy

Indexed keywords

BLEOMYCIN; CD4 ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MITOXANTRONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BLOOD DONOR; CASE REPORT; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEUROLOGIC DISEASE; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; TOXICITY;

ADULT; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-2; LEUKOCYTE TRANSFUSION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; STEM CELL TRANSPLANTATION; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036935281     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0481-4     Document Type: Article

References (13)

1. Bhatia V, Porter D (2001) Novel approaches to allogeneic stem cell therapy. Expert Opin Biol Therapy 1:3-15
2. Champlin R, Khouri I, Komblau S, Molldrem J, Giralt S (1999) Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology 13:621-628
3. Milpied N, Coste-Burel M, Accard F, Moreau A, Moreau P, Garand R, Harousseau JL (1999) Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 23:629-630
4. Porter D, Luger S, Duffy K, Stadtmauer E, Laport G, Schuster S, Orloff G, Tsai D, McDaid K, Kathakali A, Leonard D, Antin J (2001) Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation. Biol Blood Marrow Transplant 7:230-238
5. Przepiorka D, Jaeckle KA, Birdwell RR, Fuller GN, Kumar AJ, Huh YO, McCutcheon I (1997) Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 20:983-987
6. Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339-346
7. Sorensen JM, Vena DA, Fallavollita A, Chun HG, Cheson BD (1997) Treatment of refractory chronic lymphocytic leukemia with fludarabine, phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. J Clin Oncol 15:458-465
8. Cheson BD, Vena DA, Foss FM, Sorensen JM (1994) Neurotoxicity of purine analogs: a review. J Clin Oncol 12:2216-2228
9. Berger JR, Major EO (1999) Progressive multifocal leukoencephalopathy. Sem Neurol 19:193-200
10. Re D, Bamborschke S, Feiden W, Schroder R, Lehrke R, Diehl V, Tesch H (1999) Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 23:295-298
11. Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J, Brautbar C, Or R (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 87:2195-2204
12. Anderlini P, Giralt S, Andersson B, Ueno N, Khouri I, Acholonu S, Cohen A, Korbling M, Manning J, Romaguera J, Sarris A, Rodriguez M, Hagemeister F, McLaughlin P, Cabanillas F, Champlin R (2000) Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease. Bone Marrow Transplant 26:615-620
13. Porter D, Connors J, Van Deerlin V, Duffy K, McGarigle C, Saidman S, Leonard D, Antin J (1999) Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies. J Clin Oncol 17:1234-1243